Skip to content

Mental health prevention and promotion in general practice settings

Mental health prevention and promotion in general practice settings: a feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52372836
Enrollment
60
Registered
2023-07-05
Start date
2023-07-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary care mental health Mental and Behavioural Disorders

Interventions

Patients who meet the criteria and agree to participate in the study will be randomised to either: - treatment as usual within general practice - treatment as usual within general practice plus a ment

Sponsors

Lancashire & South Cumbria NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Registered at the research site's General Practice 2. Score <=14 on the GAD-7 and <=15 on the PHQ-9 at screening 3. Aged 16 years and above

Exclusion criteria

Exclusion criteria: 1. Already supported by a mental health service/ engaged in therapy 2. Score >=15 on the GAD-7 and/or >=16 on the PHQ-9 at screening 3. Have a formal diagnosis of a severe mental health difficulty, where it would not be possible to meet their needs with four sessions 4. Require support from crisis services 5. Have a moderate-severe learning disability, where their needs could only be met within a specialist service.

Design outcomes

Primary

MeasureTime frame
1. Depression measured using PHQ-9 2. Anxiety measured using GAD-7 3. Mental wellbeing measured using WEMWBS 4. Resilience measured using BRS Measured at: INTERVENTION ARM - engagement session (consent), first session (if engagement session was longer than 2 weeks ago), fourth session, Post-intervention (4-weeks post-baseline), 4-week follow up (8-weeks post-baseline), 8-week follow up (12-weeks post-baseline), 12-week follow up (16-weeks post-baseline). CONTROL ARM - engagement session (consent) and 16 weeks later.

Secondary

MeasureTime frame
Cost-effectiveness outcome measures at baseline and the final follow-up (16 weeks): 1. Patients' resource use captured using a questionnaire and patient note review. The information to be collected from the participants' electronic health records (EHR) will be: NHS Consultations and referrals; A&E admissions and stays in hospital; Prescribed medication. The EHR that will be accessed is known as EMIS- the EHR used within the GP practices in Pendle West and Burnley East PCN. The questionnaire will collate information about: Private consultations and stays; Over-the-counter medication use; Special items or equipment. 2. Patients’ health-related quality of life (HRQoL) measured using EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L; 34) questionnaire Qualitative and Process Evaluation Qualitative data will be collected to understand factors that facilitate or challenge the successful implementation of interventions and a process evaluation will be conducted to provide insight into the intervention's mechanisms of action. Participants: a patient experience questionnaire will be used to assess intervention acceptability. Semi-structured interviews will be conducted with a sample of participants (10 per arm), to explore their experience of the study and perceived mechanisms for change. General practice staff: A feedback questionnaire will be distributed to GP staff, to understand their experiences and any changes required for a full study. A semi-structured interview with three staff members will also be conducted. Research team: Field notes from the research team will identify factors that supported/impeded the feasibility study. A semi-structured interview will be conducted with the two Assistant Psychologists to understand their perceived mechanisms of change and patient safety processes. Questionnaire responses will be collated, and interviews transcribed. Qualitative analysis will be conducted by the qualitative lead, KG, using NVivo, to provide a comprehensive response to t

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026